GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luoxin Pharmaceuticals Group Stock Co Ltd (SZSE:002793) » Definitions » Long-Term Debt

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Long-Term Debt : ¥251 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Luoxin Pharmaceuticals Group Stock Co Long-Term Debt?

Luoxin Pharmaceuticals Group Stock Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥251 Mil.

Luoxin Pharmaceuticals Group Stock Co's quarterly Long-Term Debt declined from Sep. 2023 (¥544 Mil) to Dec. 2023 (¥429 Mil) and declined from Dec. 2023 (¥429 Mil) to Mar. 2024 (¥251 Mil).

Luoxin Pharmaceuticals Group Stock Co's annual Long-Term Debt declined from Dec. 2021 (¥567 Mil) to Dec. 2022 (¥191 Mil) but then increased from Dec. 2022 (¥191 Mil) to Dec. 2023 (¥429 Mil).


Luoxin Pharmaceuticals Group Stock Co Long-Term Debt Historical Data

The historical data trend for Luoxin Pharmaceuticals Group Stock Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luoxin Pharmaceuticals Group Stock Co Long-Term Debt Chart

Luoxin Pharmaceuticals Group Stock Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 463.98 303.33 567.13 190.93 429.23

Luoxin Pharmaceuticals Group Stock Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 404.89 500.50 543.66 429.23 250.75

Luoxin Pharmaceuticals Group Stock Co  (SZSE:002793) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Luoxin Pharmaceuticals Group Stock Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Luoxin Pharmaceuticals Group Stock Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Business Description

Traded in Other Exchanges
N/A
Address
85 Faraday Road, Floor 1-3, Building 1, Building 2, Pilot Free Trade Zone, Shanghai, CHN, 201203
Luoxin Pharmaceuticals Group Stock Co Ltd is a pharmaceutical enterprise engaged in research and development, production, and trade of new drugs. It manufactures drugs for various diseases including tumor, respiratory, gastrointestinal, endocrine, cardiovascular, nervous system, antimicrobial infection, among others.
Executives
Ye Bang Mi Supervisors
Fang Xiu Bao Directors, executives
Zhu Fu Lin Directors, executives
Chen Li Supervisors
Yao Liang Directors, executives

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Headlines

No Headlines